Chatterjee S, Clarke K S, Kwiterovich P O
J Biol Chem. 1986 Oct 15;261(29):13474-9.
We have investigated the effects of lipoproteins on sphingolipid metabolism in proximal renal tubular cells from normal subjects and low density lipoprotein (LDL) receptor-negative homozygous familial hypercholesterolemic subjects employing radioactive precursors, e.g. [3H]serine, [3H]glucose, and [14C]galactose. Compared to cells incubated with lipoprotein-deficient serum, maximum suppression (70-80%) of incorporation of [3H]glucose and [3H]serine into ceramide and LacCer occurred when the LDL concentration in the medium was 25 micrograms/ml medium, and addition of higher amounts of LDL (up to 500 micrograms/ml medium) to normal cells did not produce further suppression. In contrast, high density lipoproteins did not suppress the incorporation of [3H]glucose into lactosylceramide (LacCer) in normal cells. The incorporation of [14C] galactose into LacCer was also suppressed by LDL (50% suppression at a concentration of 100 micrograms/ml medium). In contrast, LDL modified by reductive methylation of lysine residues did not suppress the incorporation of [3H]glucose into LacCer and the incorporation of [3H]serine into ceramide, whereas, native LDL exerted a concentration-dependent suppression of [3H]serine incorporation into ceramide and sphingomyelin in normal cells. At high concentrations of LDL (50-500 micrograms/ml medium), the incorporation of [3H]glucose and [14C]galactose into LacCer in homozygous FH cells was stimulated approximately 2-fold. Maximum stimulation of [3H]serine incorporation into ceramides, LacCer, and sphingomyelin occurred at 100 micrograms LDL/ml medium. Our studies indicate that the endogenous synthesis of sphingolipids in normal renal cells is regulated by the LDL receptor. Modification of the lysine residues in LDL by reductive methylation results in the inability to suppress sphingolipid synthesis in normal cells. Lack of LDL receptors, as in the case of homozygous FH cells, results in the lack of suppression of endogenous sphingolipid synthesis.
我们使用放射性前体,如[3H]丝氨酸、[3H]葡萄糖和[14C]半乳糖,研究了脂蛋白对正常受试者和低密度脂蛋白(LDL)受体阴性纯合子家族性高胆固醇血症受试者近端肾小管细胞中鞘脂代谢的影响。与用缺乏脂蛋白的血清孵育的细胞相比,当培养基中LDL浓度为25微克/毫升培养基时,[3H]葡萄糖和[3H]丝氨酸掺入神经酰胺和乳糖神经酰胺的量受到最大抑制(70 - 80%),向正常细胞中添加更高量的LDL(高达500微克/毫升培养基)并未产生进一步抑制。相比之下,高密度脂蛋白不会抑制正常细胞中[3H]葡萄糖掺入乳糖基神经酰胺(LacCer)。LDL也会抑制[14C]半乳糖掺入LacCer(在浓度为100微克/毫升培养基时抑制50%)。相比之下,通过赖氨酸残基的还原甲基化修饰的LDL不会抑制[3H]葡萄糖掺入LacCer以及[3H]丝氨酸掺入神经酰胺,而天然LDL对正常细胞中[3H]丝氨酸掺入神经酰胺和鞘磷脂具有浓度依赖性抑制作用。在高浓度LDL(50 - 500微克/毫升培养基)下,纯合子FH细胞中[3H]葡萄糖和[14C]半乳糖掺入LacCer的量大约被刺激了2倍。[3H]丝氨酸掺入神经酰胺、LacCer和鞘磷脂的最大刺激作用出现在100微克LDL/毫升培养基时。我们的研究表明,正常肾细胞中鞘脂的内源性合成受LDL受体调节。通过赖氨酸残基的还原甲基化对LDL进行修饰会导致无法抑制正常细胞中的鞘脂合成。像纯合子FH细胞那样缺乏LDL受体,会导致内源性鞘脂合成缺乏抑制。